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Abstract
The exercise paradox infers that, despite the well-established cardioprotective
effects of repeated episodic exercise (training), the risk of acute atherothrom-
botic events may be transiently increased during and soon after an exercise
bout. However, the acute impact of different exercise modalities on platelet
function has not previously been addressed. We hypothesized that distinct
modalities of exercise would have differing effects on in vivo platelet activation
and reactivity to agonists which induce monocyte-platelet aggregate (MPA)
formation. Eight middle-aged (53.5  1.6 years) male participants took part
in four 30 min experimental interventions (aerobic AE, resistance RE, com-
bined aerobic/resistance exercise CARE, or no-exercise NE), in random order.
Blood samples were collected before, immediately after, and 1 h after each
intervention, and incubated with one of three agonists of physiologically/clini-
cally relevant pathways of platelet activation (thrombin receptor activating
peptide-6 TRAP, arachidonic acid AA, and cross-linked collagen-related pep-
tide xCRP). In the presence of AA, TRAP, and xCRP, both RE and CARE
evoked increases in MPAs immediately post-exercise (P < 0.01), whereas only
AA significantly increased MPAs immediately after AE (P < 0.01). These
increases in platelet activation post-exercise were transient, as responses
approached pre-exercise levels by 1 h. These are the first data to suggest that
exercise involving a resistance component in humans may transiently increase
platelet-mediated thrombotic risk more than aerobic modalities.
Introduction
Monocyte-platelet aggregates (MPAs) result from the
interaction between activated platelets and monocytes.
MPAs are considered a more sensitive marker of platelet
activation in humans than platelet surface CD62P
expression, which is rapidly cleaved from the platelet
surface and has a lower detection sensitivity by flow
cytometry (Michelson et al. 2001). Platelets become acti-
vated as a consequence of exposure to various in vivo
agonists including thrombin, collagen, and the arachi-
donic acid (AA) by-product thromboxane A2. Each of
these physiological agonists targets a different platelet
surface receptor and therefore activates platelets via
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independent pathways (Clemetson and Clemetson 2013).
Atherothrombosis is largely a platelet-mediated event
(Davi and Patrono 2007), and MPAs are elevated in
patients with stable coronary artery disease (Furman
et al. 1998) and acute myocardial infarction (Furman
et al. 2001).
Despite the well-established health benefits of long-
term exercise (Blair and Morris 2009), it is acknowledged
that the risk of an atherothrombotic event is transiently
increased in the period during and immediately following
an acute exercise bout (Thompson et al. 2007), a phe-
nomenon referred to as the “exercise paradox” (Maron
2000). While some evidence suggests there is a positive
association between the risk of acute coronary syndromes
(ACS) and exercise intensity (Mittleman et al. 1993), lit-
tle is known regarding the implications of different
modalities of exercise on transient atherothrombotic risk
and MPA formation. Three modes of exercise that are
commonly utilized in humans are steady-state aerobic
exercise (AE; walking, running, cycling), resistance exer-
cise (RE; weight lifting) and a combination of aerobic
and resistance exercise (CARE; circuit training). These
modalities are prescribed to achieve functional improve-
ments in cardiorespiratory fitness and/or skeletal muscle
strength and endurance in both primary and secondary
prevention settings (Bjarnason-Wehrens et al. 2004;
Garber et al. 2011). They are also widely utilized in the
general community in the context of personal health and
fitness training.
While the acute and chronic effects of AE, RE and
CARE on skeletal muscle and the cardiovascular system
have previously been documented (George et al. 2011;
Kraemer et al. 1995; Spence et al. 2013, 2011), no pre-
vious study has directly compared the impact of these
distinct modes of exercise on MPAs. Since AE and RE
have distinct impacts on the cardiovascular system and
skeletal muscle (Bacchi et al. 2012; Bloomer et al. 2005;
Drummond et al. 2005; Fowler et al. 2013; Heffernan
et al. 2007), we hypothesized that they may confer
divergent impacts on platelets. The aim of this study
was to investigate the acute impact of different exercise
modalities on MPAs in humans, including reactivity
of platelets to a variety of relevant physiological
platelet agonists. We hypothesized that each modality of
exercise would have different impacts on MPA
formation.
Materials and Methods
A sample size calculation was conducted for paired sam-
ples indicating that as few as three participants would be
sufficient to detect a 6% difference in MPAs with an a of
0.05 (Rosner 1995).
Ethical approval
All procedures adhered to the Declaration of Helsinki and
were approved by the Human Research Ethics Committee
of The University of Western Australia. All participants
provided written, informed consent prior to any proce-
dures being undertaken.
Participants
Eight apparently healthy male participants aged
40–65 years with no previous evidence of cardiovascular
disease were recruited from the local community in Perth,
Australia by poster advertisements placed in public places.
Individuals were defined as physically inactive following
completion of the International Physical Activity Ques-
tionnaire, taking part in <1 h of structured physical
activity a week, and exercise na€ıve in that they do not
take part in any form of regular exercise training. Those
taking prescription medications, or with musculoskeletal
injuries that would hinder their ability to exercise were
excluded. As part of the screening process, an exercise
stress test was performed in the presence of a physician
following standard guidelines (Pescatello 2014) and indi-
viduals with any evidence of exercise-induced ischemia or
arrhythmia were excluded from further participation.
Although apparently healthy, participants exhibited the
following risk factors associated with cardiometabolic dis-
ease: advancing age, physical inactivity, abdominal obe-
sity, and raised blood lipid levels. Fasting glucose and full
lipid profile blood tests were conducted, as was a dual-
energy X-ray absorptiometry (DEXA) scan to illustrate
the general characteristics of the participants included in
the study.
Preliminary sessions
Participants were familiarized with equipment, exercises,
and procedures to be included in subsequent sessions. In
two separate visits, participants completed a maximal
exercise test on a cycle ergometer, and repetition maxi-
mum (RM) strength tests for the six resistance exercises
listed below. Percentages of maximum were used to regu-
late and standardize the intensity of exercise used in sub-
sequent sessions, according to well-established principles
of exercise physiology (Garber et al. 2011).
Experimental sessions
All participants completed four experimental sessions, in
random order, with each separated by at least 7 days,
using a repeated-measures crossover design. These
included 30 min of: AE, RE, CARE, or no-exercise (NE).
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A standardized stretching routine was included in the
warm-up of all exercise sessions composed of a combina-
tion of static and dynamic stretches targeting all major
muscle groups.
Participants arrived at the laboratory in the morning
around 8 AM, having being asked to abstain from caffeine
consumption for 12 h and alcohol for 24 h. All consumed
the same carbohydrate-based breakfast including toast or
cereal, avoiding fruit, vegetables, and meat products. Par-
ticipants were specifically asked about drug use and none
used anti-inflammatory, aspirin-containing or other med-
ications that affect platelet or leukocyte function. Adher-
ence to the protocol was confirmed by questionnaire on
arrival to each session.
Participants then began a 20 min period of quiet rest
in a semirecumbent position, prior to the first blood col-
lection. This was followed by the (no) exercise activity
that was to be undertaken on that day. Following each
exercise session, participants resumed a semirecumbent
position and remained there for 1 h. Heart rate was mon-
itored during all exercise (Polar RS300X, Polar Electro
Oy, Finland).
No exercise protocol
Participants lay on a bed in a semirecumbent position for
the duration of the no-exercise session, which lasted
approximately 2.5 h.
Aerobic exercise protocol
Participants completed a 4 min warm-up on a rowing
ergometer achieving 40% heart rate reserve (HRR) by the
end of the fourth minute. The main exercise component
included 13 min on a cycle ergometer (Circle Fitness,
P&F Brothers Ind., Corp. Taiwan) at 65% Watts(W)max,
followed by 13 min on a Concept 2 PM3 rowing ergome-
ter (Concept 2 Inc., Morrisville, VT). Heart rate monitor-
ing ensured a steady-state was achieved and intensity on
the rowing ergometer was matched to the heart rate dur-
ing cycling. Heart rate, ratings of perceived exertion
(RPE) using Borg’s 6–20 scale (Borg 1970) and absolute
intensity were documented at minutes 5, 10, and 13 of
bicycle and rowing ergometry. This protocol was designed
to replicate a typical AE session used in a gymnasium
setting (Garber et al. 2011).
Resistance exercise protocol
Three sets of each resistance exercise were completed.
A 120 sec time period was allocated for each set, made up
of 40 sec working and 80 sec recovery. Firstly, participants
completed one set of each exercise with a resistance of 40%
1 RM, followed by two consecutive sets of each exercise at
65% 1 RM. Exercise stations included (1) sitting cable
chest press, (2) leg press, (3) lateral pull-down, (4) cable
shoulder press, (5) sitting machine hamstring flexion, and
(6) cable bicep curl with a rope attachment. Repetitions
were continued for the entire 40 sec working period or
until muscular failure, whichever came first. Heart rate,
RPE, and the number of repetitions completed were docu-
mented immediately following the last repetition of each
set. As for the AE session described above, we adopted an
ecologically valid approach to the design of this session,
which closely resembles typically prescribed RE.
Combined aerobic and resistance exercise
protocol
The CARE training session included all the exercises that
made up the AE and RE sessions, but with shorter recov-
ery times between RE stations so that total exercise time
was matched to the other two experimental conditions.
Participants completed three 10 min circuits; the first cir-
cuit at an intensity of 40% maximum (i.e., Wmax for AE,
1 RM for RE), and the following two circuits at 55%
maximum. Each exercise circuit consisted of six RE and
two AE, performed in the order: three RE (sitting cable
chest press, leg press, lateral pull-down), one AE (bicycle
ergometer), three RE (cable shoulder press, sitting
machine hamstring flexion and cable bicep curl with a
rope attachment), one AE (rowing), with 2 min recovery
between each circuit. Resistance exercises were allocated
60 sec (40 sec working and 20 sec transition time) and
aerobic exercises were allocated 120 sec (100 sec working
and 20 sec transition time). Heart rate, RPE, and repeti-
tions completed for resistance exercises were recorded at
the final moments of exercise at each station.
Blood collection
Venous blood was collected by separate venepunctures
from the antecubital region at three time-points during
each session; (1) before exercise (2) after exercise, and (3)
1 h post-exercise (identical time-intervals during NE),
using a 21G winged needle set (Greiner bio-one) with
minimal stasis (Harrison et al. 2011). The first 2 mL of
blood was collected into a nonadditive discard tube fol-
lowed by a 4 mL 3.2% sodium citrate tube (Vacuette by
Greiner bio-one).
Monocyte-platelet aggregates
Within 10 min of collection, blood was passed from the
3.2% sodium citrate tube and processed for the assess-
ment monocyte-platelet aggregation. Antibodies for CD14
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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(monocyte identifier) conjugated to the fluorophore Bril-
liant Violet (BV) 421 (Clone M5E2; BioLegend, San
Diego, CA) and CD42b (platelet identifier) conjugated to
Allophycocyanin (APC) (Clone HIP1; BioLegend) or IgG
isotype control (BioLegend) were used. For each blood
collection, there were nine MPA reaction tubes; isotype
control, no agonist, positive control and two concentra-
tions of the following three agonists; thrombin receptor
activating peptide-6 (TRAP-6) (SFLLRN, Sigma-Aldrich,
MO), AA (Sodium arachidonate, Bio/Data Corp., PA)
and cross-linked collagen-related peptide (xCRP) (Farn-
dale Lab, University of Cambridge, UK). Each reaction
tube contained a total liquid volume of 80 lL (20 lL of
undiluted whole blood, 40 lL of antibody cocktail made
up of saturating concentrations of CD14 BV421 and
CD42b APC in HEPES saline buffer, and 20 lL of agonist
or HEPES saline buffer in the absence of agonist). An iso-
type control was included to account for nonspecific
binding and a final concentration of 250 lM TRAP was
used as a positive control. Absence of spectral overlap
was confirmed by single-color comp bead controls (BD
Biosciences).
Blood was added to the following concentrations of
agonists; 2 lm and 5 lmol/L TRAP-6, 10 lg/mL and
125 lg/mL AA and 200 ng/mL and 1 lg/mL cross-linked
collagen-related peptide. Agonist concentrations were
determined by dose–response curve to identify submaxi-
mal and threshold concentrations, in order to demonstrate
either up- or down-regulation of platelet response to each.
Samples were incubated at room temperature with the
exception of tubes containing AA and xCRP, which were
incubated at 37°C using a dry block heater (Ratek
DBH20D, Victoria, Australia). Following exactly 15 min
incubation, all samples were fixed and red cells lysed with
800 lL of BD FACSLyse solution (BD Biosciences, CA).
Samples were then stored at 4°C in the dark and analyzed
by flow cytometry (BD FACSCantoTM II, BD Biosciences)
within 24 h at a low flow rate for 10 min per tube, to
avoid coincident events (Hui et al. 2015).
Data output from flow cytometry was analyzed using
FlowJo v.X software (FlowJo LLC., San Carlos, CA). A gating
strategy was devised to eliminate leukocyte-doublet events
(Majumder et al. 2012). Monocytes were then identified by
their characteristic forward and side scatter properties and
differential CD14 expression. Monocyte-platelet aggregates
were identified by CD42b expression above isotypic control,
and confirmed by positive control. MPAs were expressed as
the percentage of the monocyte population.
Statistics
Two concentrations (threshold and submaximal) of each
agonist were used to detect both increased and decreased
sensitivity of platelets to agonist exposure, respectively.
These data were used to calculate area under the concen-
tration curve for each agonist, at each time-point (pre,
post, 1 h-post). All of the agonist-induced MPA data,
statistics and results are presented as area under the con-
centration curve (AUC) in arbitrary units for each agonist
minus the no agonist.
Statistical analyses were performed using SPSS 22
(IBM, Armonk, NY) software. For data meeting the
assumptions of parametric statistical tests, two-way
repeated measures ANOVA’s were conducted to test for
differences between modalities, across time and interac-
tion of modality 9 time effects. If significance was found,
multiple one-way repeated measures ANOVA tests were
conducted to determine where differences occurred
within-modality over time and for corresponding time-
points between modalities, with post hoc Tukey’s least
significant difference test. For data failing the assumptions
of parametric tests, multiple nonparametric Friedman
tests were conducted for within-modality differences over
time and for corresponding time-points between the four
different modalities. Statistical significance was assumed
at P < 0.05.
Table 1. Baseline characteristics, anthropometric, dual-energy
X-ray absorptiometry (DEXA) and biochemistry variables.
Anthropometric data
Height (cm) 173  1.9
Body mass (kg) 86.2  4.1
Body mass index (kg/m2) 28.8  1.4
Waist girth (cm) 99.3  2.1
Hip girth (cm) 105.7  2.4
Waist/Hip ratio 0.94  0.01
Resting HR bpm
Heart rate 62  2
Resting blood pressure mmHg
Systolic BP 128  4
Diastolic BP 82  4
Mean arterial pressure 100  4
DEXA %
Total body fat 32.5  1.6
Body fat legs 28.4  1.9
Body fat trunk 38.2  1.7
Body fat android 43.6  1.9
Body fat gynoid 34.4  1.9
Fasting biochemistry mmol/L
Cholesterol 6.0  0.3
Triglyceride 1.8  0.2
LDL-C 4.1  0.3
HDL-C 1.1  0.1
Cholesterol/HDL ratio 5.5  0.4
Glucose 5.2  0.1
Data is mean  SEM, n = 8.
HR, heart rate; BP, blood pressure; LDL-C, low-density lipoprotein
cholesterol; HDL-C high-density lipoprotein cholesterol.
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Results
Eight men (53.5  1.6 years) completed the study. Base-
line characteristics are presented in Table 1. Data gained
from the maximal aerobic exercise test included: HRmax
176  4 bpm, time to exhaustion 11.3  0.5 min, peak
power output 173  8 watts and Vo2 peak
32.5  1.3 mL kg1 min1. Physiological data recorded
during each of the exercise bouts (AE vs. RE vs. CARE)
were as follows: HR bpm (%HRmax) 141  2 bpm
(80%) versus 122  2 bpm (69%) versus 134  1 bpm
(76%) and RPE 14  0 versus 17  0 versus 15  0.
Monocyte-platelet aggregation with acute
exercise
MPAs no agonist
In the absence of agonist stimulation, no significant dif-
ference was observed in the percentage of MPAs between
the three time-points within any experimental treatment
(mean  SEM, NE: pre 4.0  0.7%, post 3.9  0.6%,
1 h 4.4  0.7%, P = 0.197; AE: pre 3.8  0.7%, post
3.7  0.7%, 1 h 4.7  1.3%, P = 0.417; RE: pre
4.2  0.7%, post 6.5  2.0%, 1 h 4.2  0.9%, P = 0.093
and CARE: pre 4.1  0.7%, post 5.0  1.4%, 1 h
4.1  0.9%, P = 0.417). No significant difference was
found between the four modalities at pre (P = 0.615),
post (P = 0.740), and 1 h-post (P = 0.717) time-points.
Arachidonic acid
When blood samples were incubated with arachidonic
acid, significant time (P = 0.006) and time 9 modality
interaction (P = 0.003) effects were evident. As shown in
the Figure 1 (panel A), AA stimulation significantly
increased MPA area under the curve above pre-exercise
levels immediately post-exercise under all three modalities
(delta change  SEM, AE: 14.9  5.8 AUC, P = 0.038;
RE: 24.3  6.7 AUC, P = 0.009; CARE 26.8  10.5 AUC,
P = 0.039). A duration of 1 h after cessation of exercise,
MPAs significantly decreased from immediate post-
exercise levels for all modalities (delta decrease, AE;
14.0 AUC, P = 0.006, RE; 13.0 AUC, P = 0.018 &
CARE; 22.8 AUC, P = 0.009). However, MPAs were still
elevated above pre-exercise levels 1 h after RE (11.3  4.9
AUC, P = 0.05).
Comparison between modalities at corresponding
time-points indicated that no differences were found
pre-exercise (P = 0.580) or 1 h post (P = 0.468), but
significant differences were present at the immediately
post-exercise time-point (P = 0.05). Tukey’s post hoc test
indicated that compared to no-exercise (NE; 41.8  8.7
AUC), MPAs were greater following RE (56.2  10.0
AUC, P = 0.011 vs. NE) and CARE (62.0  11.0 AUC,
P = 0.038 vs. NE), but there was no difference between
NE and aerobic (AE 49.8  5.4 AUC, P = 0.491 vs. NE).
No significant differences were observed between the
three exercise protocols.
Thrombin receptor activating peptide-6
In samples incubated with TRAP, there were significant
main effects for time (P = 0.005) and interaction between
time and modality (P = 0.049). As shown in the Figure 1
(panel B), both RE and CARE resulted in significant
Figure 1. Change (mean  SE) from the ‘pre’ time-point (area
under the curve) for agonist-induced monocyte-platelet aggregate
formation. Blood collected pre, post, and 1 h post; no-exercise
(NE), aerobic exercise (AE), resistance exercise (RE) and combined
aerobic and resistance exercise (CARE), and incubated with
arachidonic acid (A), thrombin receptor activating peptide (B) and
collagen-related peptide (C). *signifies significant difference from
pre, †signifies significant difference from post (P < 0.05).
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changes in TRAP-induced MPAs over time (P = 0.001 for
each), with MPA AUC elevated above pre-exercise levels
immediately post-exercise for RE and CARE (17.4  3.7
AUC, P = 0.002 and 9.4  2.4 AUC, P = 0.005), respec-
tively. MPAs decreased from immediate post-exercise
levels following 1 hr recovery for both RE (9.3 AUC,
P = 0.002) and CARE (4.6 AUC, P = 0.024). Following
RE, MPAs at 1 h post-exercise were not different to pre-
exercise levels (P = 0.078), but were still elevated above
pre-exercise levels 1 h post-CARE (4.2  1.5 AUC,
P = 0.024). No effect was seen with NE or AE over time
(P = 0.440 and P = 0.482, respectively).
A significant difference was found between modalities
immediately post-exercise (P = 0.035) and was due to ele-
vated MPAs following RE and CARE compared to NE
(RE vs. NE, P = 0.009) (CARE vs. NE, P = 0.037). AE
was nonsignificantly elevated at this time-point
(AE 7.1  5.5 AUC vs. NE 1.8  1.3 AUC, P = 0.064).
No significant effect was observed between the modalities
at any other time-point (pre P = 0.292 and 1 h
P = 0.109).
Collagen-related peptide
When samples were incubated with xCRP (Fig. 1 panel
C), significant differences in the MPA AUC occurred over
time with participation in both RE (P = 0.010) and
CARE (P = 0.005). Compared to pre-exercise, MPAs were
significantly increased immediately post-RE (8.0  2.4
AUC, P = 0.012) and post-CARE (10.5  4.4 AUC,
P = 0.05). The decrease from immediately post to 1 h
post-exercise was significant following CARE (11.6
AUC, P = 0.012) but not post-RE (6.9 AUC,
P = 0.327). No changes were observed over time with no-
exercise (P = 0.607) or aerobic exercise (P = 0.687). No
significant differences were found between the four
modalities at corresponding time-points (pre P = 0.199,
post P = 0.154, and 1 h P = 0.615).
Discussion
Our aim was to compare the impacts of distinct forms
of exercise on platelet function in overweight and phys-
ically inactive men. This is the first study to our
knowledge in humans that has directly compared the
acute impacts of routinely prescribed (Garber et al.
2011; Kang and Ratamess 2014) exercise modalities on
monocyte-platelet aggregation in the presence agonists
of physiologically/clinically relevant pathways of platelet
activation. We found that exercise increased agonist-
induced monocyte-platelet aggregation immediately fol-
lowing exercise, with larger responses observed following
modalities which included a resistance component (both
RE and CARE). These effects of exercise on platelet
function influenced all pathways of activation we stud-
ied, induced by TRAP, arachidonic acid, and xCRP.
Finally, we observed a pattern of transient modification
to MPA production, as immediate post-exercise
responses generally returned toward baseline levels by
1 h post-exercise.
Arachidonic acid is a polyunsaturated omega-6 fatty
acid, which has diverse physiological functions that are
ultimately dependent on its metabolic fate, as AA deriva-
tives may be both pro- and anti-inflammatory (Roman
2002). Among its many derivatives and their functions,
the most relevant to the present investigation is AA’s
enzymatic conversion by cyclooxygenases to either prosta-
cyclin (inhibitor of platelet activation and vasodilator) or
thromboxane A2 (platelet activator and vasoconstrictor)
(Needleman et al. 1986) and the non-enzymatic conver-
sion to isoprostanes (Morrow et al. 1990). While the
mechanisms behind the metabolic outcomes of AA are
complex, our data indicate that AA-induced increases in
MPAs are exercise modality dependent, with larger tran-
sient impacts of the RE and CARE conditions that both
included a resistance exercise component. Arachidonic
acid-related effects on monocyte-platelet aggregation have
potential clinical significance, given the multiple roles of
its downstream by-products in terms of platelet aggrega-
tion in the atherothrombotic cascade (Frelinger et al.
2006; Pratico et al. 1997; Silver et al. 1973).
Thrombin is a central part of the coagulation cascade,
produced by the prothrombinase complex following initia-
tion of intrinsic or extrinsic coagulation. Thrombin acti-
vates platelets via cleavage of protease activated receptors,
exposing their tethered ligand (Coughlin 2000; Giri and
Jennings 2015). TRAP is the PAR-1 ligand, and is com-
monly used as a platelet agonist in the interrogation of pla-
telet function by flow cytometry (Vu et al. 1991). In
keeping with the AA results above, we observed that MPAs
transiently increased immediately following RE and CARE,
and returned to near pre-exercise levels by 1 h post-exer-
cise. No significant changes were observed in response to
AE. Our finding that hypersensitivity to TRAP occurs fol-
lowing modalities of exercise involving a resistance compo-
nent is of particular importance when considering acute
exercise as a trigger of acute coronary syndromes, since tis-
sue factor within atherosclerotic plaque is largely responsi-
ble for initiating thrombosis following atherosclerotic
plaque rupture (Toschi et al. 1997; Wilcox et al. 1989).
Mechanistically, this finding indicates that increased sensi-
tivity to platelet protease-activated receptors occurs post-
exercise in response to RE and CARE.
Collagen is a component of the subendothelium which
becomes exposed to flowing blood in the context of vas-
cular injury. Collagen binds directly to two platelet
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surface receptors; integrin a2b1 and glycoprotein (GP) VI
(Chen and Lopez 2005). Collagen also binds to von
Willebrand factor under shear, which binds to the GPIb-
IX-V complex on platelets, resulting in vascular tethering
and initiates signal transduction. Our data suggest that
the propensity for increased monocyte-platelet aggrega-
tion in response to collagen exposure is increased follow-
ing RE and CARE, with smaller changes following AE. As
in the case of AA and TRAP, this response was transient,
returning to near pre-exercise levels by 1 h post-exercise.
Overall, the data presented above suggest that exercise
involving a resistance component (i.e., RE, CARE) is
more likely to sensitize platelets to activation and the for-
mation of monocyte-platelet aggregates than other exer-
cise modalities (AE). There is some suggestion that
exercise intensity may be a factor in differential regulation
of platelet function (Hilberg et al. 2008). As steady-state
AE places continuous demand on the cardiorespiratory
systems, whereas RE is intermittent, it is possible that the
responses we found are not directly linked to cardiovascu-
lar stress, but rather linked to skeletal muscle. Indeed, if
responses in this study are intensity dependent, it is evi-
dent that despite the relatively short duration of time
actually spent exercising during RE, the influence on pla-
telets may not be nullified by the recovery periods that
separate exertional sets. With this in mind, it is important
to acknowledge that it is not possible to match the inten-
sities of steady-state aerobic exercise and intermittent
weight training without straying from the basic principles
that characterize these contrasting modalities. The inten-
tion of the exercise interventions included in this study
was to follow established guidelines for exercise prescrip-
tion of these modalities ((ACSM) 2013; Garber et al.
2011), and adopt “real-world” and relevant approaches.
Our results are therefore ecologically valid and relevant to
individuals participating in typical exercise modalities
administered to the general population.
For each of the agonists we applied, there was a “general”
pattern of transient increase in MPAs, with the highest val-
ues appearing immediately post-exercise, followed by a
return toward baseline levels. Our findings are in agreement
with recent reviews and epidemiological evidence which
suggests that increased atherothrombotic risk following
acute exercise is transient in nature (Goodman et al. 2016;
Riebe et al. 2015). Evidence also indicates that acute exer-
cise has the ability to cause rupture of thick fibrous cap
atheroma that will not commonly rupture at rest (Tanaka
et al. 2008), possibly due to increased heart rate, blood
pressure, shear stress, and/or the concomitant impact of
changes to the sympathetic nervous system and cate-
cholamine levels during exercise (Birk et al. 2013; Gjovaag
et al. 2015; MacDougall et al. 1985; Zouhal et al. 2008). In
the context of the “exercise paradox”, it is possible that
when individuals with endothelial dysfunction, arterial
stiffness, and atherosclerosis participate in acute exercise,
there is greater potential for the disruption of atheromatous
plaque (fissure, erosion, rupture) or for vascular damage to
occur, compared to physically active individuals with opti-
mal vascular function and health (Birk et al. 2012; Falk
et al. 2013; van Rosendael et al. 2015). Our findings suggest
that, if plaque disruption and/or rupture occurs during or
immediately post-exercise, resulting in exposure of the pro-
thrombotic core to flowing blood (Wilcox et al. 1989), the
consequent hyperthrombotic response may be more clini-
cally relevant following resistive exercise bouts. Nonethe-
less, our data do not suggest that acute exercise is a direct
stimulus that will consistently cause increases in platelet
activation per se.
A potential limitation to this study is that we are
unable to determine if responses are a result of the inten-
sity of RE (i.e., to muscular failure) being greater than
AE. Future research can approach this by investigating the
impact of high-intensity interval training using a common
aerobic exercise modality on agonist-induced MPAs. The
purpose of this study was to compare typically utilized
forms of exercise, that is, the forms and types of interven-
tion commonly prescribed for middle-aged men attending
a gymnasium. We therefore selected the interventions
based on observing the effects of an ecologically valid
range of exercises. While it would be possible to match
the exercise intensities between the conditions, this would
result in spurious forms of exercise that bear little rele-
vance to real world circumstances. Future research may
also compare acute responses between different popula-
tions and training status, or before and after a long period
of exercise training, to determine if the acute platelet
function responses to a single bout of exercise is modu-
lated. Finally, despite the present findings, it is important
to acknowledge that the cardiovascular risk associated
with acute exercise is small, and is far outweighed by the
many benefits gained with chronic exercise training. In
addition, the occurrence of ACS during exercise is lower
in those who are regularly active (Siscovick et al. 1984),
further emphasizing the importance of consistent partici-
pation in exercise to prevent such events.
In summary, we observed that, in the presence of
TRAP, AA, and xCRP, exercise modalities involving resis-
tance exercise evoked larger increases in platelet activation
post-exercise. This effect was transient and resiled follow-
ing 1 h of recovery. In the context of recent studies sug-
gesting that exercise may be capable of rupturing plaques
that are not susceptible under resting conditions (Tanaka
et al. 2008), these data suggest that modes of exercise
involving a resistance component may transiently increase
ACS risk more than typically administered forms of aero-
bic exercise.
ª 2016 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
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